腹股溝疝氣：見解、流行病學和市場預測（~2034年）

本報告檢視了全球七個主要國家的腹股溝疝氣市場，包括疾病背景和概述、流行病學、治療和管理概述、市場驅動因素和障礙、未滿足的需求、已上市及在研藥物概況、主要國家的市場規模趨勢和預測、競爭格局等，發現最佳機會並評估市場潛力。

目標區域

• 美國
• 5個歐洲國家（德國、法國、義大利、西班牙、英國）
• 日本

調查期間：2020-2034年

報告要點

• 由於人們對該疾病的認識不斷提高以及全球醫療保健支出的增加，預計未來幾年腹股溝疝氣市場將出現變化。
• 公司和研究機構努力分析可能影響腹股溝疝氣研究和開發的挑戰並探索機會。開發的療法著重於治療/改善疾病狀況的新方法。
• 各大公司致力於開發治療腹股溝疝氣的藥物。新治療藥物的推出預計將對市場產生重大影響。
• 開發腹股溝疝氣新療法需要更深入地了解疾病病理學。
• 對不同開發階段（第三階段和第二階段）管道資產進行深入分析，包括各種新興趨勢、詳細的臨床概況、關鍵交叉競爭、上市日期和產品線藥物開發活動比較分析，為客戶提供協助。

目錄

第1章 主要見解

第2章 腹股溝疝氣：執行摘要

第3章 腹股溝疝氣：競爭分析

第4章 腹股溝疝氣：市場概況

• 總市佔率分佈（%）：2020年
• 總市佔率分佈（%）：2034年

第5章 腹股溝疝氣：疾病背景與概述

• 徵兆和症狀
• 病理生理學
• 風險因素
• 診斷

第6章 病患旅程

第7章 腹股溝疝氣：流行病學和病患群體

• 流行病學：主要發現
• 前提/根據：7個主要國家
• 流行病學情境：7個主要國家
  • 七個主要國家的腹股溝疝氣流行病學狀況：2020-2034年
• 流行病學：美國
• 流行病學：5個歐洲國家
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 英國
• 流行病學：日本

第8章 治療演算法、目前治療藥物和醫療實踐

• 腹股溝疝氣的治療和管理
• 腹股溝疝氣的治療演算法

第9章 未滿足的需求

第10章 腹股溝疝氣治療的主要終點

第11章 推出產品

• 在 7個主要國家推出的產品列表
• 藥品名稱/公司名稱
  • 產品描述
  • 監理里程碑
  • 其他開發活動
  • 重要臨床試驗
  • 主要臨床試驗總結

第12章 新興治療藥物

• 主要交叉競爭
• 藥品名稱/公司名稱
  • 產品描述
  • 其他開發活動
  • 臨床開發
  • 安全性和有效性
  • 產品簡介

第13章 腹股溝疝氣：7個主要國家市場分析

• 主要調查結果
• 7個主要國家的市場規模
• 7個主要國家的市場規模：依治療藥物分類

第14章 屬性分析

第15章 七大國家：市場展望

• 美國：市場規模
• 歐洲五個國家：市場規模與前景
• 德國
• 法國
• 義大利
• 西班牙
• 英國
• 日本市場展望

第16章 腹股溝疝氣：取得與償付概述

第17章 KOL觀點

第18章 市場促進因素

第19章 市場障礙

第20章 附錄

第21章 DelveInsight 能力

第22章 免責聲明

第23章 關於 DelveInsight

DelveInsight's "Inguinal Hernia - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Inguinal Hernia, historical and forecasted epidemiology as well as the Inguinal Hernia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Inguinal Hernia market report provides current treatment practices, emerging drugs, Inguinal Hernia market share of the individual therapies, current and forecasted Inguinal Hernia market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Inguinal Hernia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2020-2034

Inguinal Hernia Disease Understanding and Treatment Algorithm

The DelveInsight Inguinal Hernia market report gives a thorough understanding of the Inguinal Hernia by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Inguinal Hernia.

Treatment

It covers the details of conventional and current medical therapies available in the Inguinal Hernia market for the treatment of the condition. It also provides Inguinal Hernia treatment algorithms and guidelines in the United States, Europe, and Japan.

Inguinal Hernia Epidemiology

The Inguinal Hernia epidemiology division provide insights about historical and current Inguinal Hernia patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Inguinal Hernia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Inguinal Hernia Epidemiology

The epidemiology segment also provides the Inguinal Hernia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Inguinal Hernia Drug Chapters

Drug chapter segment of the Inguinal Hernia report encloses the detailed analysis of Inguinal Hernia marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Inguinal Hernia clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Inguinal Hernia treatment.

Inguinal Hernia Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Inguinal Hernia treatment.

Inguinal Hernia Market Outlook

The Inguinal Hernia market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Inguinal Hernia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Inguinal Hernia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Inguinal Hernia market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Inguinal Hernia market in 7MM.

The United States Market Outlook

This section provides the total Inguinal Hernia market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Inguinal Hernia market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Inguinal Hernia market size and market size by therapies in Japan is also mentioned.

Inguinal Hernia Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Inguinal Hernia market or expected to get launched in the market during the study period 2020-2034. The analysis covers Inguinal Hernia market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Inguinal Hernia Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Inguinal Hernia key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Inguinal Hernia emerging therapies.

Reimbursement Scenario in Inguinal Hernia

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Inguinal Hernia domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Inguinal Hernia market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Inguinal Hernia Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

• The report covers the descriptive overview of Inguinal Hernia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Inguinal Hernia epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Inguinal Hernia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Inguinal Hernia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Inguinal Hernia market

Report Highlights:

• In the coming years, Inguinal Hernia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Inguinal Hernia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Inguinal Hernia. Launch of emerging therapies will significantly impact the Inguinal Hernia market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Inguinal Hernia
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Inguinal Hernia Report Insights

• Patient Population
• Therapeutic Approaches
• Inguinal Hernia Pipeline Analysis
• Inguinal Hernia Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Inguinal Hernia Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Inguinal Hernia Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Inguinal Hernia Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions:

Market Insights:

• What was the Inguinal Hernia market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Inguinal Hernia total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Inguinal Hernia market size during the forecast period (2024-2034)?
• At what CAGR, the Inguinal Hernia market is expected to grow in 7MM during the forecast period (2020-2034)?
• What would be the Inguinal Hernia market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Inguinal Hernia market growth till 2032, and what will be the resultant market Size in the year 2034?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What is the disease risk, burden and unmet needs of the Inguinal Hernia?
• What is the historical Inguinal Hernia patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Inguinal Hernia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Inguinal Hernia?
• Out of all 7MM countries, which country would have the highest prevalent population of Inguinal Hernia during the forecast period (2020-2034)?
• At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Inguinal Hernia treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of Inguinal Hernia in the USA, Europe, and Japan?
• What are the Inguinal Hernia marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Inguinal Hernia?
• How many therapies are developed by each company for Inguinal Hernia treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Inguinal Hernia treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Inguinal Hernia therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Inguinal Hernia and their status?
• What are the key designations that have been granted for the emerging therapies for Inguinal Hernia?
• What are the global historical and forecasted market of Inguinal Hernia?

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Inguinal Hernia market
• To understand the future market competition in the Inguinal Hernia market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Inguinal Hernia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Inguinal Hernia market
• To understand the future market competition in the Inguinal Hernia market

Table of Contents

1. Key Insights

2. Executive Summary of Inguinal Hernia

3. Competitive Intelligence Analysis for Inguinal Hernia

4. Inguinal Hernia: Market Overview at a Glance

• 4.1. Inguinal Hernia Total Market Share (%) Distribution in 2020
• 4.2. Inguinal Hernia Total Market Share (%) Distribution in 2034

5. Inguinal Hernia: Disease Background and Overview

• 5.1. Introduction
• 5.2. Sign and Symptoms
• 5.3. Pathophysiology
• 5.4. Risk Factors
• 5.5. Diagnosis

6. Patient Journey

7. Inguinal Hernia Epidemiology and Patient Population

• 7.1. Epidemiology Key Findings
• 7.2. Assumptions and Rationale: 7MM
• 7.3. Epidemiology Scenario: 7MM
  • 7.3.1. Inguinal Hernia Epidemiology Scenario in the 7MM (2020-2034)
• 7.4. United States Epidemiology
  • 7.4.1. Inguinal Hernia Epidemiology Scenario in the United States (2020-2034)
• 7.5. EU-5 Country-wise Epidemiology
  • 7.5.1. Germany Epidemiology
    • 7.5.1.1. Inguinal Hernia Epidemiology Scenario in Germany (2020-2034)
  • 7.5.2. France Epidemiology
    • 7.5.2.1. Inguinal Hernia Epidemiology Scenario in France (2020-2034)
  • 7.5.3. Italy Epidemiology
    • 7.5.3.1. Inguinal Hernia Epidemiology Scenario in Italy (2020-2034)
  • 7.5.4. Spain Epidemiology
    • 7.5.4.1. Inguinal Hernia Epidemiology Scenario in Spain (2020-2034)
  • 7.5.5. United Kingdom Epidemiology
    • 7.5.5.1. Inguinal Hernia Epidemiology Scenario in the United Kingdom (2020-2034)
  • 7.5.6. Japan Epidemiology
    • 7.5.6.1. Inguinal Hernia Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

• 8.1. Inguinal Hernia Treatment and Management
• 8.2. Inguinal Hernia Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Inguinal Hernia Treatment

11. Marketed Products

• 11.1. List of Marketed Products in the 7MM
• 11.2. Drug Name: Company Name
  • 11.2.1. Product Description
  • 11.2.2. Regulatory Milestones
  • 11.2.3. Other Developmental Activities
  • 11.2.4. Pivotal Clinical Trials
  • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

• 12.1. Key Cross
• 12.2. Drug Name: Company Name
  • 12.2.1. Product Description
  • 12.2.2. Other Developmental Activities
  • 12.2.3. Clinical Development
  • 12.2.4. Safety and Efficacy
  • 12.2.5. Product Profile

List to be continued in report

13. Inguinal Hernia: Seven Major Market Analysis

• 13.1. Key Findings
• 13.2. Inguinal Hernia Market Size in 7MM
• 13.3. Inguinal Hernia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

• 15.1. United States: Market Size
  • 15.1.1. Inguinal Hernia Total Market Size in the United States
  • 15.1.2. Inguinal Hernia Market Size by Therapies in the United States
• 15.2. EU-5 countries: Market Size and Outlook
• 15.3. Germany Market Size
  • 15.3.1. Inguinal Hernia Total Market Size in Germany
  • 15.3.2. Inguinal Hernia Market Size by Therapies in Germany
• 15.4. France Market Size
  • 15.4.1. Inguinal Hernia Total Market Size in France
  • 15.4.2. Inguinal Hernia Market Size by Therapies in France
• 15.5. Italy Market Size
  • 15.5.1. Inguinal Hernia Total Market Size in Italy
  • 15.5.2. Inguinal Hernia Market Size by Therapies in Italy
• 15.6. Spain Market Size
  • 15.6.1. Inguinal Hernia Total Market Size in Spain
  • 15.6.2. Inguinal Hernia Market Size by Therapies in Spain
• 15.7. United Kingdom Market Size
  • 15.7.1. Inguinal Hernia Total Market Size in the United Kingdom
  • 15.7.2. Inguinal Hernia Market Size by Therapies in the United Kingdom
• 15.8. Japan Market Outlook
  • 15.8.1. Japan Market Size
  • 15.8.2. Inguinal Hernia Total Market Size in Japan
  • 15.8.3. Inguinal Hernia Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Inguinal Hernia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

• 20.1. Bibliography
• 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

List of Tables

• Table 1: 7MM Inguinal Hernia Epidemiology (2020-2034)
• Table 2: 7MM Inguinal Hernia Diagnosed and Treatable Cases (2020-2034)
• Table 3: Inguinal Hernia Epidemiology in the United States (2020-2034)
• Table 4: Inguinal Hernia Diagnosed and Treatable Cases in the United States (2020-2034)
• Table 5: Inguinal Hernia Epidemiology in Germany (2020-2034)
• Table 6: Inguinal Hernia Diagnosed and Treatable Cases in Germany (2020-2034)
• Table 7: Inguinal Hernia Epidemiology in France (2020-2034)
• Table 8: Inguinal Hernia Diagnosed and Treatable Cases in France (2020-2034)
• Table 9: Inguinal Hernia Epidemiology in Italy (2020-2034)
• Table 10: Inguinal Hernia Diagnosed and Treatable Cases in Italy (2020-2034)
• Table 11: Inguinal Hernia Epidemiology in Spain (2020-2034)
• Table 12: Inguinal Hernia Diagnosed and Treatable Cases in Spain (2020-2034)
• Table 13: Inguinal Hernia Epidemiology in the UK (2020-2034)
• Table 14: Inguinal Hernia Diagnosed and Treatable Cases in the UK (2020-2034)
• Table 15: Inguinal Hernia Epidemiology in Japan (2020-2034)
• Table 16: Inguinal Hernia Diagnosed and Treatable Cases in Japan (2020-2034)
• Table 17: Drug Name, Clinical Trials by Recruitment status
• Table 18: Drug Name, Clinical Trials by Zone
• Table 19: Total Seven Major Market Size in USD, Million (2020-2034)
• Table 20: Region-wise Market Size in USD, Million (2020-2034)
• Table 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
• Table 22: United States Market Size in USD, Million (2020-2034)
• Table 23: United States Market Size by Therapy in USD, Million (2020-2034)
• Table 24: Germany Market Size in USD, Million (2020-2034)
• Table 25: Germany Market Size by Therapy in USD, Million (2020-2034)
• Table 26: France Market Size in USD, Million (2020-2034)
• Table 27: France Market Size by Therapy in USD, Million (2020-2034)
• Table 28: Italy Market Size in USD, Million (2020-2034)
• Table 29: Italy Market Size by Therapy in USD, Million (2020-2034)
• Table 30: Spain Market Size in USD, Million (2020-2034)
• Table 31: Spain Market Size by Therapy in USD, Million (2020-2034)
• Table 32: United Kingdom Market Size in USD, Million (2020-2034)
• Table 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
• Table 34: Japan Market Size in USD, Million (2020-2034)
• Table 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of tables is not exhaustive; the final content may vary

List of Figures

• Figure 1: 7MM Inguinal Hernia Epidemiology (2020-2034)
• Figure 2: 7MM Inguinal Hernia Diagnosed and Treatable Cases (2020-2034)
• Figure 3: Inguinal Hernia Epidemiology in the United States (2020-2034)
• Figure 4: Inguinal Hernia Diagnosed and Treatable Cases in the United States (2020-2034)
• Figure 5: Inguinal Hernia Epidemiology in Germany (2020-2034)
• Figure 6: Inguinal Hernia Diagnosed and Treatable Cases in Germany (2020-2034)
• Figure 7: Inguinal Hernia Epidemiology in France (2020-2034)
• Figure 8: Inguinal Hernia Diagnosed and Treatable Cases in France (2020-2034)
• Figure 9: Inguinal Hernia Epidemiology in Italy (2020-2034)
• Figure 10: Inguinal Hernia Diagnosed and Treatable Cases in Italy (2020-2034)
• Figure 11: Inguinal Hernia Epidemiology in Spain (2020-2034)
• Figure 12: Inguinal Hernia Diagnosed and Treatable Cases in Spain (2020-2034)
• Figure 13: Inguinal Hernia Epidemiology in the UK (2020-2034)
• Figure 14: Inguinal Hernia Diagnosed and Treatable Cases in the UK (2020-2034)
• Figure 15: Inguinal Hernia Epidemiology in Japan (2020-2034)
• Figure 16: Inguinal Hernia Diagnosed and Treatable Cases in Japan (2020-2034)
• Figure 17: Drug Name, Clinical Trials by Recruitment status
• Figure 18: Drug Name, Clinical Trials by Zone
• Figure 19: Total Seven Major Market Size in USD, Million (2020-2034)
• Figure 20: Region-wise Market Size in USD, Million (2020-2034)
• Figure 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
• Figure 22: United States Market Size in USD, Million (2020-2034)
• Figure 23: United States Market Size by Therapy in USD, Million (2020-2034)
• Figure 24: Germany Market Size in USD, Million (2020-2034)
• Figure 25: Germany Market Size by Therapy in USD, Million (2020-2034)
• Figure 26: France Market Size in USD, Million (2020-2034)
• Figure 27: France Market Size by Therapy in USD, Million (2020-2034)
• Figure 28: Italy Market Size in USD, Million (2020-2034)
• Figure 29: Italy Market Size by Therapy in USD, Million (2020-2034)
• Figure 30: Spain Market Size in USD, Million (2020-2034)
• Figure 31: Spain Market Size by Therapy in USD, Million (2020-2034)
• Figure 32: United Kingdom Market Size in USD, Million (2020-2034)
• Figure 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
• Figure 34: Japan Market Size in USD, Million (2020-2034)
• Figure 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of figures is not exhaustive; the final content may vary